ABT vs PATK · P/E 25, rev $44.33B vs P/E 23, rev $2.04B
Abbott Laboratories (ABT) versus Patrick Industries Inc (PATK) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Patrick Industries Inc (PATK) is a furnishings, fixtures & appliances company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported PATK revenue for 2026-06-28 was $2.04B. Net income was $82.9M. PATK currently screens at market cap $3.19B and trailing P/E 22.9.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. PATK currently screens at market cap $3.19B and trailing P/E 22.9.
Not investment advice. Open the ABT and PATK stock pages for the full models.
Not investment advice.